Diabetes medications with cardiovascular protection - What now after LEADER®? Could metformin, pioglitazone, empagliflozin and liraglutide complement each other to save lives?

Robert Ej Ryder, Ralph A. DeFronzo

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)103-106
Number of pages4
JournalBritish Journal of Diabetes and Vascular Disease
Volume16
Issue number3
DOIs
StatePublished - Jul 1 2016

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this